NHL
Showing 1401 - 1420 of 1,420
Non-Hodgkin's Lymphoma Trial in Isehara (Standard CHOP, Bi-CHOP (dose intensified CHOP))
Terminated
- Non-Hodgkin's Lymphoma
- Standard CHOP
- Bi-CHOP (dose intensified CHOP)
-
Isehara, Kanagawa, JapanTokai University
Jan 17, 2007
Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Motexafin gadolinium)
Completed
- Lymphoma
- Non-Hodgkin's Lymphoma
- Motexafin gadolinium
-
San Diego, California
- +6 more
May 11, 2007
Non-Hodgkin's Lymphoma Trial in Montreal (Yttrium 90 Ibritumomab Tiuxetan ( Zevalin ))
Unknown status
- Non-Hodgkin's Lymphoma
- Yttrium 90 Ibritumomab Tiuxetan ( Zevalin )
-
Montreal, Quebec, CanadaMcGill University Health Center, Royal Victoria Hospital
Feb 26, 2007
BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in
Unknown status
- Non-Hodgkin Lymphoma
-
Mexico City, D.f., MexicoInstituto Nacional de Cancerologia
Jan 30, 2007
Non-Hodgkin's Lymphoma Trial in United States (Zevalin (ibritumomab tiuxetan), Rituxan (rituximab))
Terminated
- Non-Hodgkin's Lymphoma
- Zevalin (ibritumomab tiuxetan)
- Rituxan (rituximab)
-
Huntsville, Alabama
- +66 more
Sep 8, 2006
B-Cell Lymphoma Trial in Belgium, France, Switzerland (Zevalin plus BEAM)
Completed
- B-Cell Lymphoma
- Zevalin plus BEAM
-
Mont-Godinne, Belgium
- +8 more
Sep 6, 2006
Lymphoma, Non-Hodgkin, Lymphoma, Low-Grade Trial in United States (ibritumomab tiuxetan (ZevalinĀ®))
Completed
- Lymphoma, Non-Hodgkin
- Lymphoma, Low-Grade
- ibritumomab tiuxetan (ZevalinĀ®)
-
Loma Linda, California
- +7 more
Oct 18, 2006
Aggressive Non-Hodgkin's Lymphoma in the Elderly. Trial in Worldwide (Cyclophosphamide, oncovin, myocet, prednisone & rituximab
Unknown status
- Aggressive Non-Hodgkin's Lymphoma in the Elderly.
- Cyclophosphamide, oncovin, myocet, prednisone & rituximab (R-COMP)
-
Paris, France
- +4 more
Oct 26, 2005
Non-Hodgkin's Lymphoma, Relapsed Lymphoma, Refractory Lymphoma Trial in Berkeley Heights (gallium nitrate)
Completed
- Non-Hodgkin's Lymphoma
- +4 more
- gallium nitrate
-
Berkeley Heights, New JerseyGenta
Feb 7, 2006
Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)
Completed
- Lymphoma, Non-Hodgkin
- Recombinant Human Interleukin-2 and Rituximab
-
Tucson, Arizona
- +32 more
Feb 2, 2006
Lymphoma, Non-Hodgkin Trial in United States (Recombinant Human Interleukin-2 and Rituximab)
Completed
- Lymphoma, Non-Hodgkin
- Recombinant Human Interleukin-2 and Rituximab
-
Little Rock, Arkansas
- +64 more
Feb 2, 2006
Non-Hodgkin's Lymphoma Trial in New York (Iodine-131 Anti-B1 Antibody)
Unknown status
- Non-Hodgkin's Lymphoma
- Iodine-131 Anti-B1 Antibody
-
New York, New YorkCornell Medical Center
Jun 23, 2005
Non-Hodgkin's Lymphoma Trial in United States (Xcellerated T Cells)
Unknown status
- Non-Hodgkin's Lymphoma
- Xcellerated T Cells
-
Greenbrae, California
- +17 more
Jun 23, 2005
Non-Hodgkin's Lymphoma Trial in Taipei (Cyclophosphamide Doxorubicin Vincristine Lamivudine)
Completed
- Non-Hodgkin's Lymphoma
- Cyclophosphamide Doxorubicin Vincristine Lamivudine
-
Taipei, TaiwanMackay Memorial Hospital
Sep 13, 2005
Non-Hodgkin's Lymphoma Trial in United Kingdom, United States (Iodine-131 Anti-B1 Antibody)
Unknown status
- Non-Hodgkin's Lymphoma
- Iodine-131 Anti-B1 Antibody
-
Palo Alto, California
- +4 more
Jun 23, 2005
Non-Hodgkin's Lymphoma Trial in Chicago, Boston, New York (Iodine-131 Anti-B1 Antibody)
Unknown status
- Non-Hodgkin's Lymphoma
- Iodine-131 Anti-B1 Antibody
-
Chicago, Illinois
- +2 more
Jun 23, 2005
Non-Hodgkin's Lymphoma Trial in United States (intravenous T900607-sodium)
Terminated
- Non-Hodgkin's Lymphoma
- intravenous T900607-sodium
-
La Jolla, California
- +4 more
Jun 23, 2005
Lymphoma, Low-Grade Trial in United States (FavId (Id-KLH) active immunotherapy)
Unknown status
- Lymphoma, Low-Grade
- FavId (Id-KLH) active immunotherapy
-
La Jolla, California
- +11 more
Jun 23, 2005
Lymphoma, Non-Hodgkin, HIV Trial in Duarte (Peripheral blood stem cells)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Peripheral blood stem cells
-
Duarte, CaliforniaCity of Hope Natl Med Ctr
Jun 23, 2005